Artillo, Jenly R.
HRN: 06-18-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/02/2022
05/08/2022
IVTT
1.5gm,
Q12
DM Foot, CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: No Wrong Dose Increase Dose
Final appropriateness: No Wrong Dose Increase Dose To 1.5g
Overall appropriateness: No Increase Dose To 1.5 G